Marcel Bavoux
Internal Medicine · Danielson, CTNPI 1508990557
Payments from drug & device makers
Across 165 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$549
- AbbVie$399
- Pfizer$337
- Boehringer Ingelheim$182
- Genentech USA, Inc.$140
- Amgen$125
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,83299%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 28 | $549 |
| AbbVie | 19 | $399 |
| Pfizer | 31 | $337 |
| Boehringer Ingelheim | 9 | $182 |
| Genentech USA, Inc. | 6 | $140 |
| Amgen | 7 | $125 |
| GSK | 8 | $119 |
| Teva Pharmaceuticals USA, Inc. | 7 | $98 |
| Sunovion Pharmaceuticals Inc. | 7 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $88 |
| Amarin Pharma, Inc. | 4 | $84 |
| Johnson & Johnson | 5 | $75 |
| Melinta Therapeutics, LLC | 4 | $69 |
| Exact Sciences | 3 | $68 |
| Lilly USA, LLC | 4 | $62 |
| Biohaven Pharmaceuticals, Inc. | 1 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Tonix Medicines, Inc. | 1 | $34 |
| Novartis | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Antares Pharma, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Shire North American Group Inc | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| Mylan Specialty L.p. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Gilead | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,874 in reported general payments places this provider in the 85th percentile of 2,067 internal medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 52 | $52,205 |
| EliquisApixaban | 30 | $38,952 |
| JanuviaSitagliptin Phosphate | 22 | $34,535 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $27,794 |
| OzempicSemaglutide | 22 | $25,455 |
| TradjentaLinagliptin | 20 | $15,880 |
| TrulicityDulaglutide | 16 | $15,227 |
| LinzessLinaclotide | 14 | $12,051 |
| Incruse ElliptaUmeclidinium Bromide | 19 | $8,008 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 47 | $6,024 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $3,669 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 112 | $2,952 |
| Levemir FlexpenInsulin Detemir | 13 | $2,154 |
| Gabapentin | 144 | $1,942 |
| Atorvastatin Calcium | 177 | $1,851 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $182 | $68,08572 claims |
| PfizerEliquis | $337 | $38,95230 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $119 | $35,80262 claims |
| Novo NordiskOzempic | $21 | $25,45522 claims |
| Lilly USA, LLCTrulicity | $62 | $15,22716 claims |
| AbbVieLinzess | $399 | $12,05114 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $16 | $52156 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,067 internal medicine providers in Connecticut.
Other internal medicine in Danielson
- Joseph SouferWaterbury$21.5M
- David RadinStamford$7M
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$2.8M
- Charles MontanoCromwell$2.8M
- Arthur DecillisMadison$1M
- Michelle MallitzTrumbull$971K
- Allen HellerWoodbridge$758K
- Gary BlickNorwalk$717K
- Margaret ChusteckaHamden$652K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.